Therapeutic hypothermia use among health care providers in 2 developing countries
Acute and Continuing Care, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
The University of Texas Medical Branch at Galveston, Galveston, TX, USA
Pilar Acosta, MD
Research Department, Dorrington Medical Associates, Houston, TX 77030, USA
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect.
Therapeutic hypothermia (TH) has been demonstrated to have beneficial effects in brain injury, cardiac arrest, perinatal asphyxia, and some cardiac and intracranial surgical procedures [1]. In 2005, the Advanced Cardiovascular Life Support and the International Liaison Committee on Resuscitation (ILCOR) guidelines recommended induced hypothermia for comatose victims of cardiac arrest [2]. The recommendations included inducing TH at 32°C to 34°C for 12 to 24 hours when the initial presenting rhythm was ventricular fibrillation (class IIA recommendation) or nonventricular fibrillation (class IIb recommendation) [3].
To access this article, please choose from the options below
Purchase access to this article
Claim Access
If you are a current subscriber with Society Membership or an Account Number, claim your access now.
Subscribe to this title
Purchase a subscription to gain access to this and all other articles in this journal.
Institutional Access
Visit ScienceDirect to see if you have access via your institution.
© 2007 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
Access this article on
Visit ScienceDirect to see if you have access via your institution.
Article Tools
Related Articles
Searching for related articles..
